News from the Pharmacy Guild of Australia

Every Tuesday the Pharmacy Guild of Australia provides a news update which features in the newsletter. See below for the latest news from the Pharmacy Guild of Australia.

Guild Column

Posted: Tue 19 Apr 16

Guild Update – 19 April 16 : Safe use of codeine

THE Pharmacy Guild is currently conducting the national rollout of MedsASSIST - the codeine real-time system that will help pharmacists monitor consumer use of codeine containing products to ensure safe and effective use.

Posted: Tue 12 Apr 16

Guild Update – 12 April 16 : Ask Your Pharmacist

NEW health advice topics ranging from eye health to depression have been launched on the Guild’s consumer campaign website, Ask Your Pharmacist.

Posted: Tue 05 Apr 16

Guild Update – 5 April 16 : Hep C medicines on the PBS

THE Guild welcomes and supports the recent listing of hepatitis C medicines on the PBS and the recognition of the role community pharmacists can play in assisting people with the condition.

Posted: Tue 29 Mar 16

Guild Update – 29 March 16 : National Rollout: MedsASSIST – Informing Medicine Decisions

THE national rollout of MedsASSIST is now underway.

Posted: Tue 22 Mar 16

Guild Update – 22 March 16 : Health Advice Plus

A NEW Pharmacy Guild program called Health Advice Plus will change the way pharmacies deliver professional services, and add to the value of community pharmacy for Australian patients.

Posted: Tue 15 Mar 16

Guild Update 15 March 16 : APP week!

WE ARE now in the final hours leading up to this year’s Australian Pharmacy Professional (APP) conference - the most significant event on the Australian pharmacy calendar.

Posted: Tue 08 Mar 16

Guild Update – 8 March 16 : Flu vaccines in ACT

IT’S terrific news that ACT community pharmacists have been given the green light to administer flu vaccinations to their patients in time for the upcoming flu season.

Posted: Tue 01 Mar 16

Guild Update – 1 March 16 : Hepatitis C – New Medicines PBS Listings Information

GUILD Members would be aware that the Government has approved listing of the following medicines for hepatitis C from 1 March 2016: • Daclatasvir (Daklinza®) 30 mg tablet, 28 DPMQ $7,813.54 • Ledipasvir with sofosbuvir (Harvoni®) 90 mg + 400 mg tablet, 28 DPMQ $22,213.54 • Sofosbuvir (Sovaldi®) 400 mg tablet, 28 DPMQ $19,444.62 • Ribavirin (Ibavyr®) 400 mg tablet, 28 DPMQ $160.95 and 600 mg tablet 28, $237.81 High Cost Members should note the high cost of some of these medicines.